| 61 |
Role of cardiac magnetic resonance in predicting response to cardiac resynchronization therapy |
2020 |
| 62 |
Role of cardiac magnetic resonance in predicting response to cardiac resynchronization therapy |
2020 |
| 63 |
Role of cardiac magnetic resonance in predicting response to cardiac resynchronization therapy |
2020 |
| 64 |
Safety and Efficacy of adding Dapagliflozin to Furosemide in Type 2 Diabetic Patients with Decompensated Heart Failure and Reduced Ejection Fraction |
2020 |
| 65 |
Subclinical left ventricular systolic dysfunction by two-dimensional speckle-tracking echocardiography and its relation to ambulatory arterial stiffness index in hypertensive patients |
2020 |
| 66 |
Superiority of cardiac magnetic resonance imaging over echocardiography in early detection of subclinical cardiac abnormalities in systemic lupus erythematosus patients |
2020 |
| 67 |
Superiority of cardiac magnetic resonance imaging over echocardiography in early detection of subclinical cardiac abnormalities in systemic lupus erythematosus patients |
2020 |
| 68 |
Assessment of Subclinical Left Ventricular Systolic Dysfunction by SpeckleTracking Echocardiography and its Relation to Ambulatory Blood Pressure Parameters in Hypertensive Patients |
2019 |
| 69 |
Assessment of Subclinical Left Ventricular Systolic Dysfunction by SpeckleTracking Echocardiography and its Relation to Ambulatory Blood Pressure Parameters in Hypertensive Patients |
2019 |
| 70 |
Assessment of Subclinical Left Ventricular Systolic Dysfunction by SpeckleTracking Echocardiography and its Relation to Ambulatory Blood Pressure Parameters in Hypertensive Patients |
2019 |
Do you have any questions? 
